(Total Views: 662)
Posted On: 09/07/2020 10:57:19 PM
Post# of 148988
Ohm20
Your research and information is invaluable to this community. Thank you!
I have a question for you or others here...
With this huge list, what is the process and potential for trials. I understand that doctors can proscribe off label once approved, but will cytodyn run trials on all these in your opinion. Once revenue starts i would assume there would be enough cash flow to fund and organize numerous trials as well as staff up the corporate office to organize and support. I would assume they would target the largest need or cash flow potential.
What do you see as potential research and uses. I would imagine that without a trial and listing a patient would have to put up a pretty big fight to get LL for their diagnosis when it isnt FDA approved for the application. I would assume it would be the rare doctor to venture off standard protocol.
I ask because i have two family members that have been diagnosed with Alzheimers and Lewy Dementia (which is not on your list and my brief research is not good enough to tunnel down to what makes it tick. Seems to be deposits in brain cells disrupting normal action, but i cant figure out what makes the deposits occur and maybe the researchers dont know either)
Needless to say, I doubt either could be a candidate for LL at this stage of developement and approval. I dont think the Alzheimers study has really started in NY either. Lewy i doubt is on anyones radar.
So given that it seems to me that usage for Alzheimers and most of your other indications is realistically a few years off. I would assume that trials would take at least a year or more per indication depending on the type of disease as well as time for FDA to grant approval.
Am I off base or pretty close to your thoughts?
Your research and information is invaluable to this community. Thank you!
I have a question for you or others here...
With this huge list, what is the process and potential for trials. I understand that doctors can proscribe off label once approved, but will cytodyn run trials on all these in your opinion. Once revenue starts i would assume there would be enough cash flow to fund and organize numerous trials as well as staff up the corporate office to organize and support. I would assume they would target the largest need or cash flow potential.
What do you see as potential research and uses. I would imagine that without a trial and listing a patient would have to put up a pretty big fight to get LL for their diagnosis when it isnt FDA approved for the application. I would assume it would be the rare doctor to venture off standard protocol.
I ask because i have two family members that have been diagnosed with Alzheimers and Lewy Dementia (which is not on your list and my brief research is not good enough to tunnel down to what makes it tick. Seems to be deposits in brain cells disrupting normal action, but i cant figure out what makes the deposits occur and maybe the researchers dont know either)
Needless to say, I doubt either could be a candidate for LL at this stage of developement and approval. I dont think the Alzheimers study has really started in NY either. Lewy i doubt is on anyones radar.
So given that it seems to me that usage for Alzheimers and most of your other indications is realistically a few years off. I would assume that trials would take at least a year or more per indication depending on the type of disease as well as time for FDA to grant approval.
Am I off base or pretty close to your thoughts?
(0)
(0)
Yours Truly
Lamont
#1 30.58333 114.26667
#2 39.002744, -77.103470
Lamont
#1 30.58333 114.26667
#2 39.002744, -77.103470
Scroll down for more posts ▼
